Skip to main content
. 2021 Jan 18;22(2):925. doi: 10.3390/ijms22020925

Figure 4.

Figure 4

Overall survival (OS) analysis among patients with NSCLC undergoing first-line chemotherapy, according to the baseline detection of CTCs by using the CellSearch or the CEACAM5mRNA assay alone (AC) or in combination (D,E).